PM-technique produced magnesium-alloy bio-nanocomposite porous scaffolds with carbamide as porogen. Mg samples were alloyed with Ca, Zn, and Sr for enhanced mechanical performance and deterioration resistance. Nano-fluorcanasite, a bioactive-chain-silicate glass-ceramic reinforcement, was added to the magnesium-metal-matrix to induce new bone cell growth. Dip-coating was used to coat bare magnesium samples with PCL. FE-SEM-EDS findings showed gradient-porosity and coating thickness of 70–90 µm. After 28-days of immersion, C-S1 and C-S2 had compressive and residual-compressive strengths 10% to 15% higher than C-S0. As Ca, Zn, and Sr hydroxyapatites formed, C-S1 and C-S2 degradation reduced with immersion time. Biodegradation matches immersion liquid pH, hydrogen gas evolution, and cytocompatibility. As porosity increased from 50% to 60%, scaffold compressive strength and modulus decreased but remained in line with that of a human cancellous bone. PCL-coated customized nanocomposite magnesium alloy-based biomaterials may be promising biodegradable bone tissue repair implant materials with configurable mechanical and degradable attributes.
No takes yet. Share an insight, caveat, or question.
Garimella et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: